Skip to content

David C. Dale, MD

NPI 1871633354ActiveIndividual· Internal Medicine· Seattle, WA

Internal Medicine (MD) in Seattle, Washington, licensed in WA, with an NPI issued in February 2007. Part D covered 95 prescriptions written in 2024, 96% of them generic. X4 Pharmaceuticals, Inc. was the largest of 3 companies reporting payments in 2025, $7,821 in all, mostly consulting fees.

Overview

NPI1871633354
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedFeb 7, 2007
Last updated in NPPESJan 12, 2012

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine Primary207R00000XMD00012172WA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Internal Medicine (WA)

Part D prescriptions in 2024

Prescriptions (claims)95 · 258 30-day fills
Patients20
Total drug cost$1,215
Generic share96% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$7,821 · 5 payments from 3 companies
  • 2024$1,689 · 3 payments from 2 companies

Top paying companies in 2025

CompanyAmountPayments
X4 Pharmaceuticals, Inc.$4,2701
Insmed, Inc.$2,8013
Merck Sharp & Dohme LLC$750.001

What the 2025 payments were for

  • Consulting Fee$7,821 · 5 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine providers in Seattle

All Internal Medicine providers in Washington →